3C
EGRX

361 Capital’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

361 Capital’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-21,809
Closed -$1.51M – 429
2018
Q3 		$1.51M Buy
+21,809
New +$1.51M 0.33% 181
2018
Q1 		– Sell
-39,599
Closed -$2.12M – 353
2017
Q4 		$2.12M Buy
+39,599
New +$2.12M 0.52% 90